Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The use of ozone therapy in Buruli ulcer had an excellent outcome.

Literature DB >> 23376670

The use of ozone therapy in Buruli ulcer had an excellent outcome.

Antonella Bertolotti¹, Annunziata Izzo, Pier Giovanni Grigolato, Maria Letizia Iabichella.

Abstract

This is the first case reporting the effective use of 2 weeks of ozone therapy for the treatment of Buruli ulcer (BU), a dramatic disease caused by Mycobacterium ulcerans, an epidemic in central Africa. This simple and cheap treatment could become an effective option for managing BU as an alternative to antibiotic or surgical treatments.

Entities: Disease Species

Mesh：

Substances：
Ozone

Year: 2013 PMID： 23376670 PMCID： PMC3604502 DOI： 10.1136/bcr-2012-008249

Source DB: PubMed Journal: BMJ Case Rep ISSN： 1757-790X

10 in total

Review 1. [Relapses after surgical treatment of Buruli ulcer in Africa].

Authors: A K Kibadi
Journal: Bull Soc Pathol Exot Date: 2006-10

2. Buruli ulcer. A disabling infection.

Authors:
Journal: Prescrire Int Date: 2010-11

3. Buruli ulcer: progress report, 2004-2008.

Authors:
Journal: Wkly Epidemiol Rec Date: 2008-04-25

4. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.

Authors: S Etuaful; B Carbonnelle; J Grosset; S Lucas; C Horsfield; R Phillips; M Evans; D Ofori-Adjei; E Klustse; J Owusu-Boateng; G K Amedofu; P Awuah; E Ampadu; G Amofah; K Asiedu; M Wansbrough-Jones
Journal: Antimicrob Agents Chemother Date: 2005-08 Impact factor: 5.191

5. Factors enhancing the control of Buruli ulcer in the Bomfa communities, Ghana.

Authors: Pius Agbenorku; Margaret Agbenorku; Adela Amankwa; Lawrence Tuuli; Paul Saunderson
Journal: Trans R Soc Trop Med Hyg Date: 2011-06-08 Impact factor: 2.184

Review 6. Buruli ulcer.

Authors: Thorbjorg Einarsdottir; Kris Huygen
Journal: Hum Vaccin Date: 2011-11-01

7. Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR.

Authors: T Stinear; B C Ross; J K Davies; L Marino; R M Robins-Browne; F Oppedisano; A Sievers; P D Johnson
Journal: J Clin Microbiol Date: 1999-04 Impact factor: 5.948

8. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.

Authors: Willemien A Nienhuis; Ymkje Stienstra; William A Thompson; Peter C Awuah; K Mohammed Abass; Wilson Tuah; Nana Yaa Awua-Boateng; Edwin O Ampadu; Vera Siegmund; Jan P Schouten; Ohene Adjei; Gisela Bretzel; Tjip S van der Werf
Journal: Lancet Date: 2010-02-03 Impact factor: 79.321

9. Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).

Authors: Kapay Kibadi; Marleen Boelaert; Alexandra G Fraga; Makanzu Kayinua; Adhemar Longatto-Filho; Jean-Bedel Minuku; Jean-Baptiste Mputu-Yamba; Jean-Jacques Muyembe-Tamfum; Jorge Pedrosa; Jean-Jacques Roux; Wayne M Meyers; Françoise Portaels
Journal: PLoS Negl Trop Dis Date: 2010-07-06

10. Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin.

Authors: Daniela Schütte; Alphonse Um-Boock; Ernestina Mensah-Quainoo; Peter Itin; Peter Schmid; Gerd Pluschke
Journal: PLoS Negl Trop Dis Date: 2007-10-31